Russell Stothard
PHILADELPHIA—Scientists in the UK and Uganda have now completed a three year study showing that young children are at continued risk of intestinal schistosomiasis — also known as bilharzia — between the ages of 6-months and five years. In fact, these children should be treated routinely with the anthelminthic praziquantel, just as in older children and adults, for it is proven both safe and efficacious. The Schistosomiasis In Mothers and Infants (SIMI) study was conducted by the Liverpool School of Tropical Medicine and the London School of Hygiene & Tropical Medicine working with the Vector Control Division, Ministry of Health, in Uganda and was reported at the American Society of Tropical Medicine and Hygiene annual conference in Philadelphia. Professor Russell Stothard discussed some of the key findings with Peter Goodwin.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.